DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX) on May 08, 2024. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company. Upon closing, the shareholders of DNA will become the majority owners of SRAX?s outstanding common stock.

Upon the completion of the merger, the public company plans to change its name to DNA Holdings Venture Inc and to request to change its ticker symbol, creating a public company which will allow investors to gain exposure to the most cutting edge Web3 technology projects. Christopher Miglino will act as the CEO of the combined entity. The boards of directors of SRAX and DNA have unanimously approved the proposed Transaction.

The Transaction is subject to, among other things, the approval of both SRAX and DNA stockholders and satisfaction or waiver of the conditions stated in the Agreement.